- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Surgical ablation during CABG increased survival in atrial fibrillation patients: Study

A recent study published in The Annals of Thoracic Surgery suggests that despite strong clinical guidelines, the use of surgical ablation during coronary artery bypass grafting (CABG) in patients with atrial fibrillation (AF) remains low and potentially life-shortening.
The study reviewed data from over 87,000 Medicare beneficiaries who had preexisting atrial fibrillation and underwent CABG between 2008 and 2019. This revealed that only 22.2% received concomitant surgical ablation. This technique targets the abnormal electrical signals causing AF and was associated with significantly improved long-term survival.
This study found that patients who received surgical ablation during CABG lived a median of 4.4 months longer than those who did not. Also, risk-adjusted median survival was 7.82 years in the ablation group when compared to 7.46 years in the non-ablation group (P < .001).
The survival benefit was even more pronounced when looked at the surgeon practice patterns. The patients operated on by surgeons who frequently perform ablation (defined as doing so in ≥40% of their CABG cases) had a median survival advantage of nearly 5 months (4.96 months) when compared to the patients treated by infrequent ablation surgeons (<5% of cases). Median survival in this analysis was 7.03 years versus 6.62 years, respectively (P < .001).
While the survival gains may appear modest on paper, the public health impact is substantial, given the high volume of CABG procedures and the prevalence of atrial fibrillation in older adults. This study argues that the findings support current guideline recommendations advocating for surgical ablation in AF patients undergoing CABG and spotlight a significant gap between evidence-based guidance and real-world practice.
In a detail examination, 652 surgeons (frequent ablation) performed the procedure in ≥40% of their CABG patients, 1834 surgeons (occasional ablation) performed it in 5–40% of cases and 1193 surgeons (infrequent ablation) did so in <5% of cases. These numbers suggest that a large proportion of cardiac surgeons either rarely or inconsistently offer this beneficial procedure.
As the study brought out, improving adherence to surgical ablation guidelines could meaningfully enhance long-term outcomes for tens of thousands of cardiac surgery patients every year. Overall, while surgical ablation during CABG clearly offers survival advantages, it remains underutilized, which calls for an urgent need for practice alignment with current evidence and guidelines.
Reference:
Schaffer, J. M., Kluis, A., Squiers, J. J., George, T. J., Shih, E., Banwait, J. K., Mack, M. J., & DiMaio, J. M. (2025). Survival after surgical ablation of atrial fibrillation during coronary artery bypass in Medicare beneficiaries. The Annals of Thoracic Surgery. https://doi.org/10.1016/j.athoracsur.2025.03.044
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751